Inoue, H., Taji, H., Yamada, K., Iriyama, C., Saito, T., Kato, H., . . . Matsukawa, N. (2020). Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia. Intern Med.
Chicago Style CitationInoue, Hiroyasu, Hirofumi Taji, Kentaro Yamada, Chisako Iriyama, Touko Saito, Harumi Kato, Masamitsu Yanada, Kazuhito Yamamoto, i Noriyuki Matsukawa. "Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia." Intern Med 2020.
Cita MLAInoue, Hiroyasu, et al. "Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia." Intern Med 2020.